What is the prognosis associated with various Pediatric Sequential Organ Failure Assessment (pSOFA) scores?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediatric SOFA Score Prognosis

Higher pSOFA scores, particularly ≥8, are strongly associated with increased mortality in critically ill children, with serial measurements over days 2-4 showing superior prognostic accuracy compared to admission scores.

Prognostic Performance by Score Threshold

The pSOFA score demonstrates clear mortality stratification in pediatric sepsis and critical illness:

  • pSOFA ≥8: Associated with significantly increased mortality risk, with sensitivity improving from 47.4% on day 1 to 63.2% on day 4 1
  • Serial measurement advantage: Discriminative power increases substantially over time, with adjusted AUROC for mortality prediction rising from 0.69 on day 1 to 0.88 on day 4 1
  • Day 2-3 optimal timing: pSOFA measured on day 2 provides comparable predictive accuracy (AUROC 0.940) to more complex scores like PRISM III 2

Comparative Performance with Other Scores

The pSOFA performs well but is not always superior to disease-specific alternatives:

  • In fluid-refractory septic shock, PELOD-2 shows slightly better sensitivity (84.2% vs 63.2% on day 4) and discrimination (AUROC 0.90 vs 0.88) 1
  • For general pediatric sepsis, pSOFA demonstrates good mortality discrimination with AUROC of 0.83, comparable to PELOD-2 (0.82) and Phoenix Sepsis Score (0.79) 3
  • In resource-limited settings, pSOFA ≥6 at admission is associated with increased mortality 3

Clinical Application Algorithm

For mortality risk stratification in critically ill children:

  1. Calculate baseline pSOFA at admission - provides initial risk assessment (AUROC ~0.69-0.83)
  2. Reassess on day 2-3 - this is the optimal window for prognostication, with AUROC improving to 0.88-0.94
  3. Interpret thresholds:
    • pSOFA <6: Lower mortality risk
    • pSOFA 6-7: Intermediate risk, requires close monitoring
    • pSOFA ≥8: High mortality risk, consider escalation of care and family discussions
  4. Monitor trajectory: Increasing scores across multiple organ systems indicate poor prognosis 4

Important Caveats

Critical limitations to recognize:

  • Not validated in infants: SOFA scores have not been validated as mortality predictors in infants and very young children 4
  • Context matters: The score was developed for adult populations and adapted for pediatrics; disease-specific scores may perform better in certain conditions 2
  • Serial measurement essential: Single admission scores have limited predictive value; monitoring organ dysfunction trajectory over 2-4 days is most useful 4, 5
  • Resource considerations: In resource-limited settings where laboratory capacity is constrained, simpler clinical discriminators (need for mechanical ventilation, vasopressor-dependent shock) may be more practical 4, 6

Organ Failure Patterns

Specific prognostic indicators:

  • Persistence of 3-4 organ failures at day 3-7 predicts mortality with 93-100% specificity 5
  • Very high total scores are particularly worrisome 4
  • Failure of clinical improvement or increasing scores across multiple organ systems generally indicates poor prognosis 4

The pSOFA serves as a practical, objective tool for mortality prediction in pediatric critical illness, with optimal utility when measured serially over the first 2-4 days of ICU admission 1, 7, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.